Am J Psychiatry 1986; 143:88-90
Copyright © 1986 by American Psychiatric Association
Pituitary-adrenocortical hyperfunction and intolerance to fluvoxamine, a selective serotonin uptake inhibitor
WA Brown, M Arato and R Shrivastava
Of nine nonsuppressors on the dexamethasone suppression test (DST), five
(56%) developed intolerable side effects during treatment with fluvoxamine,
a new serotonin uptake inhibiting antidepressant, compared with three of 24
suppressors (13%).